Typical response of CD14++CD16– monocyte to knee synovial derived mediators as a key target to overcome the onset and progression of osteoarthritis
Nik Syazana Izyan Saffery(University of Malaya), Tunku Kamarul(University Malaya Medical Centre), Iekhsan Othman(Monash University Malaysia), Mohamed Zubair Mohamed Al-Fayyadh(University of Malaya), Seow Hui Teo(University of Malaya), Syafiq Asnawi Zainal Abidin(Monash University Malaysia), Khairul Anwar Ayob(University of Malaya), Krishnamurithy Genasan(University of Malaya), Chee Ken Chan(University of Malaya), Murali Malliga Raman(University of Malaya), Hanumantha Rao Balaji Raghavendran(Sri Ramachandra Institute of Higher Education and Research)
Cited by 10
Related Papers
HMGB1: A Common Biomarker and Potential Target for TBI, Neuroinflammation, Epilepsy, and Cognitive Dysfunction
|Frontiers in Neuroscience|2018|318
Current strategies in extending half-lives of therapeutic proteins
|Journal of Controlled Release|2019|285
Impact of HMGB1, RAGE, and TLR4 in Alzheimer’s Disease (AD): From Risk Factors to Therapeutic Targeting
|Cells|2020|257
Mangrove rare actinobacteria: taxonomy, natural compound, and discovery of bioactivity
|Frontiers in Microbiology|2015|178
Enlightening the role of high mobility group box 1 (HMGB1) in inflammation: Updates on receptor signalling
|European Journal of Pharmacology|2019|175